MITCHELL SANDERS: Open Payments
NPI 1528680162 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 21 payments from 14 companies in 2025. Trend: 2023 $463 · 2024 $612 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $76 |
| Boston Scientific Corporation | 2 | $70 |
| GlaxoSmithKline, LLC. | 3 | $43 |
| Lilly USA, LLC | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Dexcom, Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
| Viatris Specialty LLC | 1 | $23 |
| ACADIA Pharmaceuticals Inc | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
Products named: WATCHMAN Access System, Ozempic, AREXVY, KISUNLA, Dexcom G6 Transmitter, FREESTYLE LIBRE 3, Rybelsus, YUPELRI.
Industry payments across IL — which companies pay providers there.
